---
$id: https://graph.org.ai/products/commodity/51392210
$type: Product
source: UNSPSC
code: "51392210"
title: "Medetomidine"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Medetomidine

**UNSPSC Code**: 51392210
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MR15E85MQM, chemically known as 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)- but generally known as medetomidine, which bears US NIH Compound Identifier 68602. European Medicines Agency schedules Medetomidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08691MIG. The term MEDETOMIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). MEDETOMIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule medetomidine under HS 29332990 and SITC 51573. As of Q4 2014, MEDETOMIDINE remains the US FDA Preferred Term for this commodity. Medetomidine bears US NLM identifiers UMLS ID C0125656 and NCI Concept Code C81367. SMILES: CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.

